ORCHARD: A biomarker-directed phase 2 platform study in pts with advanced EGFRm NSCLC progressing on first-line osimertinib Meeting Abstract
| Authors: | Cho, B. C.; Piotrowska, Z.; Le, X.; Goldberg, S. B.; Goldman, J.; De Langen, A.; Okamoto, I.; Smith, P.; Mensi, I.; Maidment, J.; Hartmaier, R.; Li, M.; Doughton, G.; Patel, G.; Pease, J.; Szekeres, P.; Riess, J.; Yu, H. |
| Abstract Title: | ORCHARD: A biomarker-directed phase 2 platform study in pts with advanced EGFRm NSCLC progressing on first-line osimertinib |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | non-small cell lung cancer; resistance; osimertinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S598 |
| Language: | English |
| ACCESSION: | WOS:000631349601502 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.1084 |
| Notes: | Meeting Abstract: P76.27 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
